Published in Cancer Lett on January 21, 2013
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer. J Immunother Cancer (2017) 1.39
Intratumoral immunization: a new paradigm for cancer therapy. Clin Cancer Res (2014) 1.24
High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer. PLoS One (2013) 1.04
Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer. PLoS One (2015) 0.90
Prognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomy. J Gastroenterol (2014) 0.89
Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes. PLoS One (2014) 0.89
Macrophages: Their Emerging Roles in Bone. J Bone Miner Res (2015) 0.88
Harnessing the immune system for the treatment of breast cancer. J Zhejiang Univ Sci B (2014) 0.85
Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments. Cancer Lett (2013) 0.85
The oncogenic potential of human cytomegalovirus and breast cancer. Front Oncol (2014) 0.85
Autophagy proteins regulate cell engulfment mechanisms that participate in cancer. Semin Cancer Biol (2013) 0.83
Clinical and Pathological Findings Associated with Aerosol Exposure of Macaques to Ricin Toxin. Toxins (Basel) (2015) 0.83
PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles. J Nucl Med (2015) 0.83
Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer. Theranostics (2015) 0.82
Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis. Clin Transl Oncol (2015) 0.82
Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models. Dis Model Mech (2016) 0.82
Cyclooxygenase-2 in tumor-associated macrophages promotes breast cancer cell survival by triggering a positive-feedback loop between macrophages and cancer cells. Oncotarget (2015) 0.81
Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice. Biomed Res Int (2014) 0.81
Small cell lung cancer: Recruitment of macrophages by circulating tumor cells. Oncoimmunology (2015) 0.80
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy. Clin Breast Cancer (2015) 0.80
Inflammatory cell distribution in primary merkel cell carcinoma. Cancers (Basel) (2014) 0.80
Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC). Curr Signal Transduct Ther (2014) 0.80
Persistent breast pain following breast cancer surgery is associated with persistent sensory changes, pain interference, and functional impairments. J Pain (2014) 0.80
4T1 Murine Mammary Carcinoma Cells Enhance Macrophage-Mediated Innate Inflammatory Responses. PLoS One (2015) 0.79
TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer. Oncoimmunology (2015) 0.78
In Vivo Visualization of Stromal Macrophages via label-free FLIM-based metabolite imaging. Sci Rep (2016) 0.78
Drug Trafficking into Macrophages via the Endocytotic Receptor CD163. Membranes (Basel) (2015) 0.78
Macrophages support splenic erythropoiesis in 4T1 tumor-bearing mice. PLoS One (2015) 0.78
Upregulation of microRNA-181b inhibits CCL18-induced breast cancer cell metastasis and invasion via the NF-κB signaling pathway. Oncol Lett (2016) 0.77
Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness. Oncol Lett (2016) 0.77
Targeted Proteomics Enables Simultaneous Quantification of Folate Receptor Isoforms and Potential Isoform-based Diagnosis in Breast Cancer. Sci Rep (2015) 0.76
Hypoxia-inducible factor-mediated induction of WISP-2 contributes to attenuated progression of breast cancer. Hypoxia (Auckl) (2014) 0.75
Quantifying tumor associated macrophages in breast cancer: a comparison of iron and fluorine-based MRI cell tracking. Sci Rep (2017) 0.75
Jagged1 modulated tumor-associated macrophage differentiation predicts poor prognosis in patients with invasive micropapillary carcinoma of the breast. Medicine (Baltimore) (2017) 0.75
Nanomedicines for dysfunctional macrophage-associated diseases. J Control Release (2017) 0.75
The prognostic and predictive value of the lymphocyte to monocyte ratio in luminal-type breast cancer patients treated with CEF chemotherapy. Oncotarget (2016) 0.75
Tumor-associated macrophages: from basic research to clinical application. J Hematol Oncol (2017) 0.75
Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer. Eur Arch Otorhinolaryngol (2014) 0.75
Cytomegalovirus, Macrophages and Breast Cancer. Open Virol J (2017) 0.75
"Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma. PLoS One (2017) 0.75